Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-19T20:36:57.895Z Has data issue: false hasContentIssue false
  • English
  • Français

Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine

Published online by Cambridge University Press:  16 April 2020

D. Goldstein ,
I. Bitter ,
Y. Lu ,
M. Detke ,
C. Wiltse ,
C. Mallinckrodt  and
M. Demitrack
D. Goldstein
Affiliation:
Eli Lilly & Company, Austria
I. Bitter
Affiliation:
Eli Lilly & Company, Austria
Y. Lu
Affiliation:
Eli Lilly & Company, Austria
M. Detke
Affiliation:
Eli Lilly & Company, Austria
C. Wiltse
Affiliation:
Eli Lilly & Company, Austria
C. Mallinckrodt
Affiliation:
Eli Lilly & Company, Austria
M. Demitrack
Affiliation:
Eli Lilly & Company, Austria

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Posters, Sunday, 5 May 2002
Information
European Psychiatry , Volume 17 , Issue S1 , May 2002 , pp. 98s
Copyright
Copyright © Elsevier, Paris 2002
Submit a response

Comments

No Comments have been published for this article.